Dr. Andrea Perrone
Consultant
Andrea Perrone, M.D., is a seasoned leader with extensive expertise in clinical imaging and global clinical trial operations. Dr. Perrone had a leadership role at GEHealthcare in developing imaging contrast agents. Additionally, she established core principles and standardized imaging processes across therapeutic areas at Merck, where she built and led a team of imaging professionals. She contributed to the development of the novel immunotherapy imaging criteria, 'iRECIST,' and provided regulatory support for Keytruda filings. Her leadership in clinical imaging and operational support has been instrumental in achieving high-quality trial execution and regulatory success, resulting in over 100 label approvals during her tenure at Merck.
Dr. Perrone brings her extensive and deep expertise in global clinical trial imaging to Arc Nouvel along with operational excellence in order to advance innovative therapies for patients across the industry.
